BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 22443336)

  • 1. Combined modality treatments in pancreatic cancer.
    Lombardi L; Troiano M; Silvestris N; Nanni L; Latiano TP; Di Maggio G; Cinieri S; Di Sebastiano P; Colucci G; Maiello E
    Expert Opin Ther Targets; 2012 Apr; 16 Suppl 2():S71-81. PubMed ID: 22443336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodality approaches for pancreatic cancer.
    Yang GY; Wagner TD; Fuss M; Thomas CR
    CA Cancer J Clin; 2005; 55(6):352-67. PubMed ID: 16282280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
    Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
    Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoradiotherapy for pancreatic cancer: current status and perspectives.
    Oya N
    Int J Clin Oncol; 2004 Dec; 9(6):451-7. PubMed ID: 15616875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative chemoradiation for pancreatic cancer.
    Evans DB
    Semin Oncol; 2005 Dec; 32(6 Suppl 9):S25-9. PubMed ID: 16399426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant therapy for pancreatic cancer: current status and future directions.
    Xiong HQ; Abbruzzese JL
    Surg Oncol Clin N Am; 2004 Oct; 13(4):737-49, xi. PubMed ID: 15350945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Carcinoma of the pancreas: current status of multimodal therapy].
    Keck T
    Zentralbl Chir; 2011 Aug; 136(4):352-8. PubMed ID: 21773958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant therapy for pancreatic cancer: the Duke experience.
    White RR; Tyler DS
    Surg Oncol Clin N Am; 2004 Oct; 13(4):675-84, ix-x. PubMed ID: 15350941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in the management of pancreatic adenocarcinoma.
    Karakas Y; Lacin S; Yalcin S
    Expert Rev Anticancer Ther; 2018 Jan; 18(1):51-62. PubMed ID: 29125367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neoadjuvant and adjuvant therapy of ductal pancreatic carcinoma].
    Hohenberger W; Kastl S
    Zentralbl Chir; 2000; 125(4):348-55. PubMed ID: 10829315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic cancer today.
    Safioleas MC; Moulakakis KG
    Hepatogastroenterology; 2004; 51(57):862-8. PubMed ID: 15143935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic cancer: current and future treatment strategies.
    Pliarchopoulou K; Pectasides D
    Cancer Treat Rev; 2009 Aug; 35(5):431-6. PubMed ID: 19328630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing treatment effect in pancreatic cancer.
    Hartman DJ; Krasinskas AM
    Arch Pathol Lab Med; 2012 Jan; 136(1):100-9. PubMed ID: 22208494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Borderline resectable pancreatic cancer: definitions and the importance of multimodality therapy.
    Evans DB; Erickson BA; Ritch P
    Ann Surg Oncol; 2010 Nov; 17(11):2803-5. PubMed ID: 20737218
    [No Abstract]   [Full Text] [Related]  

  • 15. Adjuvant treatments for resectable pancreatic cancer.
    Ueno H; Kosuge T
    J Hepatobiliary Pancreat Surg; 2008; 15(5):468-72. PubMed ID: 18836798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathology-based risk stratification of muscle-invasive bladder cancer patients undergoing cystectomy for persistent disease after induction chemoradiotherapy in bladder-sparing approaches.
    Koga F; Fujii Y; Masuda H; Numao N; Yokoyama M; Ishioka J; Saito K; Kawakami S; Kihara K
    BJU Int; 2012 Sep; 110(6 Pt B):E203-8. PubMed ID: 22289431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Surgical therapy of locally advanced and primary inoperable pancreatic carcinoma after neoadjuvant preoperative radiochemotherapy].
    Rau HG; Wichmann MW; Wilkowski R; Heinemann V; Sackmann M; Helmberger T; Dühmke E; Schildberg FW
    Chirurg; 2002 Feb; 73(2):132-7. PubMed ID: 11974476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Systemic chemotherapy and chemoradiotherapy for advanced pancreatic cancer].
    Ueno H; Okusaka T
    Gan To Kagaku Ryoho; 2012 Mar; 39(3):357-63. PubMed ID: 22421761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative chemoradiation followed by surgical resection for resectable pancreatic cancer: a review of current results.
    Chua TC; Saxena A
    Surg Oncol; 2011 Dec; 20(4):e161-8. PubMed ID: 21704510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does preoperative therapy optimize outcomes in patients with resectable pancreatic cancer?
    Papalezova KT; Tyler DS; Blazer DG; Clary BM; Czito BG; Hurwitz HI; Uronis HE; Pappas TN; Willett CG; White RR
    J Surg Oncol; 2012 Jul; 106(1):111-8. PubMed ID: 22311829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.